Pulike Biological Engineering, Inc. (603566.SS)
CNY 13.78
(1.32%)
CNY 13.78
(1.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.26 Billion CNY | -3.67% |
| 2022 | 3.38 Billion CNY | 56.19% |
| 2021 | 2.16 Billion CNY | 6.87% |
| 2020 | 2.02 Billion CNY | 6.47% |
| 2019 | 1.9 Billion CNY | 0.13% |
| 2018 | 1.9 Billion CNY | 5.43% |
| 2017 | 1.8 Billion CNY | 3.93% |
| 2016 | 1.73 Billion CNY | 15.5% |
| 2015 | 1.5 Billion CNY | 79.5% |
| 2014 | 837.72 Million CNY | 14.65% |
| 2013 | 730.67 Million CNY | 25.52% |
| 2012 | 582.13 Million CNY | 16.3% |
| 2011 | 500.56 Million CNY | 13.37% |
| 2010 | 441.53 Million CNY | 35.33% |
| 2009 | 326.25 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.09 Billion CNY | -1.53% |
| 2024 Q1 | 3.2 Billion CNY | -1.75% |
| 2024 Q2 | 3.13 Billion CNY | -2.06% |
| 2023 Q4 | 3.26 Billion CNY | -2.53% |
| 2023 Q1 | 3.38 Billion CNY | -0.11% |
| 2023 FY | 3.26 Billion CNY | -3.67% |
| 2023 Q3 | 3.34 Billion CNY | 0.5% |
| 2023 Q2 | 3.32 Billion CNY | -1.57% |
| 2022 Q1 | 2.24 Billion CNY | 3.49% |
| 2022 Q4 | 3.38 Billion CNY | 3.81% |
| 2022 FY | 3.38 Billion CNY | 56.19% |
| 2022 Q3 | 3.26 Billion CNY | 42.1% |
| 2022 Q2 | 2.29 Billion CNY | 2.31% |
| 2021 Q1 | 2.11 Billion CNY | 4.37% |
| 2021 Q3 | 2.12 Billion CNY | 2.87% |
| 2021 Q2 | 2.06 Billion CNY | -2.67% |
| 2021 Q4 | 2.16 Billion CNY | 2.27% |
| 2021 FY | 2.16 Billion CNY | 6.87% |
| 2020 Q4 | 2.02 Billion CNY | 7.83% |
| 2020 FY | 2.02 Billion CNY | 6.47% |
| 2020 Q2 | 1.83 Billion CNY | -0.54% |
| 2020 Q3 | 1.88 Billion CNY | 2.49% |
| 2020 Q1 | 1.84 Billion CNY | -3.12% |
| 2019 Q4 | 1.9 Billion CNY | 3.93% |
| 2019 Q1 | 1.88 Billion CNY | -1.05% |
| 2019 Q2 | 1.82 Billion CNY | -3.33% |
| 2019 Q3 | 1.83 Billion CNY | 0.71% |
| 2019 FY | 1.9 Billion CNY | 0.13% |
| 2018 Q1 | 1.83 Billion CNY | 1.76% |
| 2018 FY | 1.9 Billion CNY | 5.43% |
| 2018 Q4 | 1.9 Billion CNY | 2.46% |
| 2018 Q3 | 1.85 Billion CNY | 2.31% |
| 2018 Q2 | 1.81 Billion CNY | -1.16% |
| 2017 Q2 | 1.72 Billion CNY | -1.8% |
| 2017 Q3 | 1.76 Billion CNY | 2.43% |
| 2017 Q4 | 1.8 Billion CNY | 2.03% |
| 2017 FY | 1.8 Billion CNY | 3.93% |
| 2017 Q1 | 1.75 Billion CNY | 1.28% |
| 2016 Q2 | 1.53 Billion CNY | -0.46% |
| 2016 Q1 | 1.54 Billion CNY | 2.75% |
| 2016 Q4 | 1.73 Billion CNY | 8.38% |
| 2016 Q3 | 1.6 Billion CNY | 4.19% |
| 2016 FY | 1.73 Billion CNY | 15.5% |
| 2015 Q1 | 843 Million CNY | 0.63% |
| 2015 Q4 | 1.5 Billion CNY | 2.02% |
| 2015 Q3 | 1.47 Billion CNY | 4.23% |
| 2015 Q2 | 1.41 Billion CNY | 67.75% |
| 2015 FY | 1.5 Billion CNY | 79.5% |
| 2014 Q4 | 837.72 Million CNY | 0.0% |
| 2014 FY | 837.72 Million CNY | 14.65% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 730.67 Million CNY | 25.52% |
| 2012 FY | 582.13 Million CNY | 16.3% |
| 2011 FY | 500.56 Million CNY | 13.37% |
| 2010 FY | 441.53 Million CNY | 35.33% |
| 2009 FY | 326.25 Million CNY | 0.0% |